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The insertion/deletion polymorphism in the gene for the regulator of vascular tone,
angiotensin-converting enzyme (ACE), is the prototype of a genetic influence on physical
fitness and this involves an influence on capillary supply lines and dependent aerobic
metabolism in skeletal muscle. The respective interaction of ACE-I/D genotype and
training status on local metabolic and angiogenic reactions in exercised muscle is not
known. Toward this end we characterized the metabolomic and angiogenic response
in knee extensor muscle, m. vastus lateralis, in 18 untrained and 34 endurance-trained
(physically active, V˙O2max > 50mL min−1 kg−1) white British men to an exhaustive
bout of one-legged cycling exercise. We hypothesized that training status and ACE-I/D
genotype affect supply-related muscle characteristics of exercise performance in
correspondence to ACE expression and angiotensin 2 levels. ACE-I/D genotype and
training status developed an interaction effect on the cross-sectional area (CSA) of
m. vastus lateralis and mean CSA of slow type fibers, which correlated with peak
power output (r ≥ 0.44). Genotype × training interactions in muscle also resolved
for exercise-induced alterations of 22 metabolites, 8 lipids, glycogen concentration
(p = 0.016), ACE transcript levels (p = 0.037), and by trend for the pro-angiogenic factor
tenascin-C post exercise (p = 0.064). Capillary density (p = 0.001), capillary-to-fiber
ratio (p = 0.010), systolic blood pressure (p = 0.014), and exercise-induced alterations
in the pro-angiogenic protein VEGF (p = 0.043) depended on the ACE-I/D genotype
alone. Our observations indicate that variability in aerobic performance in the studied
subjects was in part reflected by an ACE-I/D-genotype-modulated metabolic phenotype
of a major locomotor muscle. Repeated endurance exercise appeared to override this
genetic influence in skeletal muscle by altering the ACE-related metabolic response and
molecular aspects of the angiogenic response to endurance exercise.
Keywords: muscle, exercise, endurance performance, muscle fibers, gene polymorphism, metabolism,
metabolome analysis
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INTRODUCTION
Perfusion of the capillary bed is a critical determinant of
maximal tissue metabolism as it sets the capacity for substrate
uptake (Wagner, 1996; Bassett and Howley, 2000; Sarelius
and Pohl, 2010). This dependence manifests with endurance
training when most subjects demonstrate compensatory
adaptations within the capillary bed of skeletal muscle, such as
enhanced endothelium-dependent vasodilatation of arterioles
and increased capillarisation (Egginton, 2009; Mortensen et al.,
2014). The regulatory processes being implicated in exercise-
induced vascular adaptations comprise a rapidly increased
blood flow with the onset of muscle contractions (Clifford
and Hellsten, 2004; Egginton, 2009). With the repetition of
exercise the consequent elevation in microvascular shear stress
stimulates in conjunction with abluminal mechanical factors
morphogenic adaptations and proliferation of endothelial cells
in muscle capillaries (Bassett and Howley, 2000; Gustafsson and
Kraus, 2001; Prior et al., 2003). The consequent adaptations in
muscle capillarisation manifest in a typical 20–40% increase in
capillary density or capillary-to-fiber ratio after a sufficiently
intense and long training stimulus such as exhaustive endurance
exercise when sessions are repeated 5 times per week over 4–8
weeks (Hoppeler et al., 1985; Schmutz et al., 2010; Busso and
Flück, 2013; Egan and Zierath, 2013). Thereby signs of capillary
remodeling in exercised muscle are already detectable 3–12 h
into recovery from a single exercise session by virtue of altered
muscle expression of angiogenesis-associated gene transcripts
(Clifford and Hellsten, 2004; Egginton, 2009; Schmutz et al.,
2010).
Inhibition of vasoconstriction is a main factor contributing to
the rapid increase in blood flowwithmuscle contraction (Clifford
and Hellsten, 2004) and the subsequent angiogenic response
(Mathes et al., 2015). The overriding of angiotensin 2-mediated
constriction of peripheral blood vessels is a major regulatory
switch for increased perfusion of muscle capillaries with
exercise (Korthuis, 2011). Angiotensin 2 is produced through
the action of endothelial-associated dipeptidipeptidyl-carbo-
peptidase angiotensin converting enzyme (ACE) in perfused
blood vessels and there is evidence for exercise-modulated
production of angiotensin 2 production (Staessen et al., 1987; van
Ginkel et al., 2015b). At rest, and in healthy subjects, angiotensin
2 production mainly arises from ACE being associated with the
lung endothelium and kidney (Igic and Behnia, 2003; Brewster
and Perazella, 2004). With intense exercise, angiotensin 2 levels
in blood sizably increase (Staessen et al., 1987; van Ginkel
et al., 2015a), pointing to the implication of ACE activity in
organs which become increasingly perfused during exercise
(Igic and Behnia, 2003; Maeda et al., 2005; Korthuis, 2011).
Correlations of exercise-induced changes in serum angiotensin
levels with capillary density (Vaughan et al., 2016) in skeletal
muscle emphasize the possible contribution of a muscle-based
ACE enzyme, aside the lung-based ACE activity, to angiotensin
2 production and angiotensin-regulated muscle perfusion with
exercise (Vaughan et al., 2013, 2016; van Ginkel et al., 2015b).
The ACE-I/D gene polymorphism is a prominent sequence
variation within the ACE gene, which exerts a distinct influence
on the tissue expression and serum activity of ACE; and
angiotensin 2 production (reviewed by Tiret et al., 1992; van
Ginkel et al., 2015b; Vaughan et al., 2016). It is characterized
by the insertion (I), or deletion (D), of a 287-basepair long
silencer region in intron 16 of the ACE gene (Rigat et al., 1990);
whereby the presence of the I-allele generally lowers stability
of the ACE transcript (reviewed by Tiret et al., 1992; Mizuiri
et al., 2001; Vaughan et al., 2013). ACE-I/D dependent vaso-
regulation is reflected in a higher degree of capillary recruitment
and perfusion with intense leg exercise in ACE-II genotypes
that do not carry the D-allele (Vaughan et al., 2013, 2016;
van Ginkel et al., 2015b). ACE-I/D genotype-related differences
in the capacity for muscle perfusion develop a considerable
effect on activity-induced metabolism. In young healthy subjects,
this manifests through reduced aerobic combustion of glucose
in mitochondria and up-regulated anaplerotic reactions in
ACE-DD genotypes immediately after exhaustive endurance
exercise on a cycle ergometer; giving rise to an exaggerated
depletion of muscle glycogen with exhaustive endurance exercise
(Vaughan et al., 2016). The ACE I/D genotype –dependent
metabolic reactions are related to differences in capillarisation
and mean cross sectional area of muscle fibers in a major knee
extensor muscle, m. vastus lateralis (Vaughan et al., 2016). This
metabolic differentiation supports an enhanced improvement
in oxidative muscle characteristics, such as the volume density
of subsarcolemmal mitochondria and intramyocellular lipid
(Vaughan et al., 2013, 2016), in ACE- I-allele carriers with
endurance training.
The mechanism underlying the effect of ACE involves a direct
action of angiotensin 2 on the proliferation and differentiation
of smooth muscle cells and endothelial cells, and indirect effects
on endothelial cells through angiotensin 2 modulated shear
stress which drives angiogenesis (Britten et al., 1999; Duncker
and Bache, 2008; Clapp et al., 2009; Szostak and Laurant,
2011). In this regard we have recently reported that genetic and
pharmacological inhibition of ACE influences the expression
of pro-angiogenic and mitochondrial transcripts in leg muscle
after bicycle-type endurance exercise (Mathes et al., 2015).
Specifically, the expression of shear stress-related gene transcripts
after exercise was enhanced, while expression of hypoxia-related
transcripts was lowered under pharmacological inhibition of
ACE (van Ginkel et al., 2016).
The ACE-I/D polymorphism has been calculated to account
for only a fraction of inter-subject differences in ACE activity
levels, serum angiotensin concentration and blood pressure
(Danser et al., 2007). The findings indicate that additional
factors, or confounders, which affect the ACE system and
water homeostasis must play a role of regulation of ACE,
such as prior exercise, thermal environment and water intake
(Kosunen et al., 1976; Staessen et al., 1987; Danser et al.,
2007). The endurance training state is possibly an important
confounder, because it affects the capacity for exercise-induced
muscle perfusion through an improvement in exercise-induced
vasodilatation and increase of the capillary bed (Egginton et al.,
1998; Flück and Hoppeler, 2003; Mortensen et al., 2014). In fact,
endurance training state is an important factor, which affects
the angiogenic response to exercise (Busso and Flück, 2013;
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Hoier et al., 2013), in association with improved vasodilatative
and capacitive mechanism of muscle perfusion and aerobic
metabolism (reviewed in Flück and Hoppeler, 2003; Clifford and
Hellsten, 2004; Egginton, 2009; Korthuis, 2011; Mortensen et al.,
2014). In turn this affects shear stress and tissue oxygenation-
mediated control of angiogenic factor expression and action
(Zumstein et al., 1983; Wibom et al., 1992; Egginton et al., 2001;
Dapp et al., 2006; Williams et al., 2006). One aspect in this
regard is the enhanced production and secretion of endothelium
associated proteins during exercise as shown for VPF/VEGFA
(vascular perfusion factor/vascular endothelial growth factor)
(Hoier et al., 2013). Therefore, the aim of this investigation
was to assess (1) whether the reported ACE-I/D genotype
associated angiogenic and metabolic features of knee extensor
muscle are modified by the endurance training state, and (2)
whether the genetic effect is related to the local ACE system
(ACE activity, transcript expression and angiotensin 2 blood
serum concentration), the expression response of oxygenation-
and shear stress-regulated pro-angiogenic proteins, VEGFA and
tenascin-C, and metabolic reactions, which have been shown to
depend on ACE-activity (Mathes et al., 2015; Vaughan et al.,
2016), after exhaustive exercise. The latter aspect was addressed
with an exploratory approach to identify muscle metabolite and
lipid species that would demonstrate an influence of the ACE-I/D
genotype and training status.
METHODS
Subjects
Healthy, non-diabetic, 18–40 years old white men of British
descent with a BMI between 20 and 30 kg m−2 were recruited
via advertisement in local newspapers. In total, 52 subjects
volunteered for the investigation. The study has been conducted
with permission of the Ethics committee of Manchester
Metropolitan University according to published guidelines
(Harriss and Atkinson, 2011). All investigations were performed
in accordance with the ethical standards of the 1964 Declaration
of Helsinki. Written informed consent was obtained from every
participant.
Design
Physical activity levels, medical health, quality of life and dietary
status of the subjects was assessed by a validated questionnaire
(36-Item Short-Form Health Survey questionnaire; Ware and
Sherbourne, 1992; Howley et al., 2003), basic anthropometry,
imaging based assessment of body composition and quadriceps
muscles. Aerobic fitness was estimated based on a two-legged
V˙O2peak test on a stationary cycle ergometer. One-week later
subjects performed a standardized single bout of exhaustive one-
legged cycle exercise under the collection of biopsies prior to,
0.5 and 8 h post cycling exercise from vastus lateralis muscle.
The collected biopsies were used to quantify muscle composition,
ACE transcript levels and activity, VEGFA and tenascin-
C protein content, and muscle metabolites. The ACE-I/D
polymorphism was determined in a double-blind manner from a
mucosal swab as collected during the functional exploration and
assessed post-hoc for its influence only after the physiological and
biochemical measurements had been performed. For the analysis
subjects were group ed based on their training status and ACE-
I/D genotype as assessed by questionnaire, functional exploration
and genotyping. Subjects were deemed to be endurance-trained
if they documented a history of 5 years of regular endurance
type training (endurance running, cycling, football, rugby),
documented a level of intense physical activity above 6 h per week
(in the 36-Item Short-Form Health Survey questionnaire), and if
they demonstrated a V˙O2peak above 50mLmin−1 kg−1. Healthy
subjects which complied to the inclusion criteria, but which
documented a level of intense physical activity below 6 h per
week or demonstrated a V˙O2peak below 50mLmin−1 kg−1 were
considered as not being endurance-trained, i.e., being untrained.
Imaging Based Assessment of Body
Composition and Quadriceps Muscles
Whole body scans were run with Dual Energy X-ray
Absorptiometry (DEXA) with a Lunar Prodigy Advance
densitometer (GE Healthcare, Waukesha, Wisconsin, USA)
to estimate body fat and calculate fat-free-mass as described
previously (George et al., 1997). Participants lay supine on the
scanning bed.
Magnetic resonance imaging (MRI) was used to measure
cross-sectional area (CSA) within the quadriceps muscle group of
the exercising leg (one-legged V˙O2peak test). Participants were
scanned using a 0.25-T G-scan MRI scanner (Esaote, Genova,
Italy) in the supine position with the leg fully extended and
relaxed, and held in place. A turbo 3D-T1-weighted protocol was
used (matrix 256 × 256, TR 40ms, TE 16ms) and multiple 3.1-
mm thick serial transverse sections were obtained every 25mm
from the distal to the proximal heads of the femur. Computing
imaging software (OsiriX medical imaging software, OsiriX,
Atlanta, USA) was used to determine the CSA of the m. vastus
lateralis the quadriceps group at 50% of the femur length (Morse
et al., 2007). The length of the femur was defined as the distance
between the greater trochanter and the distal lateral condyle at
the knee.
Two-Legged V˙O2peak Test
This assessment comprised ergospirometric measurements of
aerobic performance, aerobic capacity and respiration during
aerobic exercise tests to the limit of tolerance on an electrically
braked cycle ergometer (Ergoline 800S; Ergoline GmbH, Bitz,
Germany). Saddle length was adjusted to a position where the
knee was extended at an ∼175◦ angle when subjects were seated
with the shoe heel placed on the pedal. The handlebar position
was adjusted to a position allowing to a comfortable position.
Power output, inspired and expired air (Cosmed K4b2, Italy), and
heart rate was monitored with an Accurex Plus chest belt, Polar
Electro Finland, Kempele, Finland).
The test started with a 4-min warm-up at 40 Watts at 80 rpm.
Following the external work rate was increased by 5 Watts every
10 s until volitional exhaustion. The test was terminated when the
pedal rate fell consistently below 70 rpm. Immediately following
termination of the test, the participants were encouraged to
perform an active recovery by cycling at a very low external
workload. Test results were analyzed oﬄine for absolute and
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specific, i.e., body mass-related peak oxygen uptake (V˙O2peak),
peak power output (PPO), and RER following exercise. V˙O2peak
was identified as the highest 30-s average oxygen uptake. RER at
the beginning of the test was assessed from the average over a 15-s
interval 2min into the warm up. Maximum RER was determined
from the average of a 15-s interval from the end of the test.
Single Bout of Exhaustive One-Legged
Cycle Exercise
This stimulus was completed using the subject’s dominant leg
on the electrically braked cycle ergometer (Ergometrics Ergoline
800; Jaeger, Bitz, Germany) based on the values determined
during the functional exploration.
Subjects were asked to reduce physical activity in the 3 days
before the test and to report to the laboratory in the fasted state.
The pedal on the side of the non-dominant leg was taken off and
the corresponding non-active leg was placed on a fixed chair.
Saddle length was set to the same value used for two-legged
exercise. The exercising foot was then taped securely in place,
with strong electrician’s tape. Blood pressure was measured in a
calm place in seated position with a sphygmomanometer after
the subject has been sitting for at least 15min. Subjects then
performed the exercise bout to voluntary exhaustion. This started
with a 5-min warm-up at a cadence of 80 rpm under and at 15%
of the two-legged PPO. Next, the subjects exercised for 25min
at 30% of the two-legged PPO. Subsequently the intensity was
ramped up in 10-Watt increments each minute until exhaustion.
The intensity was not further increased when the pedal rate fell
consistently below 60 rpm despite strong verbal encouragement.
At the end of the exercise period, a 3-min cool-down phase was
allowed at 15% of the calculated two-legged PPO.
Power output, inspired and expired oxygen and carbon
dioxide was monitored during the exercise using a (Cosmed
K4b2, Italy) and used to calculate absolute and relative peak
power output and V˙O2peak.
Biopsy Collection
Prior to exercise, a small (∼50–100mg) biopsy was taken
under sterile conditions using a conchotome from the vastus
lateralis muscle of the non-exercising leg. Biopsy position was
standardized to 50% of femur length as assessed by prior
ultrasound analysis. Lidocaine (2%) was infiltrated under the skin
prior to performing the skin incision. The biopsy was placed
on a wax plate, blotted dry and separated into two pieces. The
first piece was frozen within 1min after collection in liquid
nitrogen cooled iso-pentane and stored in sealed 2-mL cryotubes
(Nunc, Sigma, Buchs, Switzerland) at −80◦C. The second
sample was immediately mounted on cork (orientating the fibers
longitudinally) and frozen within 3min after collection using
Tissue-Tek (Sakura, AJ Alphen aan den Rijn, The Netherlands),
and then frozen in cold isopentane. All samples were then stored
at −80◦C until later analysis. 30-min post exercise fine needle
biopsies were collected using a spring-loaded instrument (ACE-
Onecut Disposable Biopsy, 14 Gauge × 150mm, UK BIOPSY
Ltd, Great Britain). Samples were frozen and stored as indicated
above.
Muscle Composition
Mean CSA and percentage of muscle fiber types, capillary
number and capillary-to-fiber ratio, were determined based on
established protocols. In brief, cryo-sections were prepared from
the frozen biopsy portion, which was mounted on cork. Care was
taken to orient the cutting angle in perpendicular direction to the
major axis of the muscle fibers.
For the assessment of muscle fiber types 10 µm-thick
cryo-sections were quenched in 3% H2O2, blocked in 3%
BSA/PBS and reacted in 0.3% BSA/PBS with slow (MAB1628,
Chemicon-Merck Millipore, Burlington, Massachusetts, USA)
or fast (My-32, Sigma Chemicals, Buchs, Switzerland) myosin-
specific antibodies and horse radish peroxidise-conjugated anti-
mouse IgG (A-2304 Sigma Chemicals, Buchs, Switzerland,
1:2,000) essentially as described previously (Vaughan et al., 2016).
Immuno-reactivity was detected with substrate AEC (Sigma
Chemicals, Buchs, Switzerland), the slides were mounted with
Aquatex (MERCK) and non-overlapping microscopic fields of
the stained section recorded using a light microscope (Carl Zeiss,
Oberkochen, Germany). Fiber number and CSAs of type I (slow)
and type II (fast) muscle fibers, respectively, were quantified
using image J 1.6.0_33 J (http://imagej.nih.gov/ij) as described
previously (Li et al., 2013). On average 130 fibers were measured
per cross-section.
The number of capillaries per square millimeter (capillary
density) and the capillary-to-fiber ratio was determined based on
morphometric evaluation of lectin-stained, 14 µm-thick cryo-
sections according to the published settings (van Ginkel et al.,
2015a). On average 68 muscle fibers per cross-section were
analyzed.
Genotyping
The ACE-I/D genotype was determined essentially as described
previously (Vaughan et al., 2016). The collected mucosal
swab was frozen at −20◦C in a sealed 15mL tube (Sarstedt;
Nümbrecht; Germany). DNAwas extracted from the frozen swab
after thawing with repeated vortexing the tip of the swap in 800
µL of methanol. The solution was air dried, frozen over-night
at −80◦C and resuspended in 100 µL of sterile water under
heating to 65◦C. DNA was recovered in the supernatant after
a centrifugation step (5,000 g, 2min, room temperature) and
stored at −20◦C. Genotyping for the ACE-I/D polymorphism
with polymerase chain reaction (PCR) was carried out in a
double-blind manner. Specifically, sample codes were blinded
by a second investigator by sticking a label with random,
but unique, four letter codes on top. The code was handed
to a third investigator unrelated to the study. Subsequently
the DNA samples were subjected together with mock and
camouflage samples to a PCR reaction essentially as described
previously (Evans et al., 1994). The primers corresponded
to those established previously for the identification of the
ACE-I/D genotype (for details see Genbank number X62855):
detection of the 83-bp-amplicon specific to the absence of
the insertion sequence (i.e., the D-allele) was achieved by
a combination of ACE1 (5′-CATCCTTTCTCCCATTTCTC-3′)
and ACE3 (5′-ATTTCAGAGCTGGAATAAAATT-3′) primers.
ACE2 (5′-TGGGATTACAGGCGTGATACAG-3′) and ACE3
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(5′-ATTTCAGAGCTGGAATAAAATT-3′) primers were applied
to detect the 66-bp-amplicon specific for the I-allele in intron
16 of the ACE gene. PCR reactions were run with a mix
of the three primers using Sybr Green master mix (Applied
Biosystems) on an Applied Biosystems Real Time PCR system
(SepOnePlus, Life Technologies). This involved 45 standard
cycles of denaturing at 95◦C for 15 s followed by annealing and
extension at 55◦C for 1min. Amplicon identification followed
using a melting curve analysis between a temperature range
of 70◦-80◦C. The identity of the amplified sequences was
validated by sequencing of the PCR product with specific primers
(Microsynth, Balgach, Switzerland). Subsequently, the presence
of the short amplicon for the I-allele was identified based on
a lower melting temperature (73.5◦C; 72.5–74◦C) compared
to the longer D-allele (75.5◦C; 74.5–76.5◦C) respectively. The
genotyping results were decoded through the involvement of
the third investigator once the functional test and metabolic
measures had been completed.
ACE Transcript Expression in Skeletal
Muscle
RNA isolation and real-time polymerase chain reaction was
carried out essentially as described previously (Zoll et al.,
2006; van Ginkel et al., 2016). In brief, total RNA was
isolated from a homogenate of pooled 20-µm thick cryo-
sections corresponding to a volume of 10-mm3 biopsy using
a rotor-stator homogenizer (Polytron PT1200, KINEMATICA
AG, Lucerne, Switzerland) and the RNeasy Mini Kit (Qiagen,
cat N◦ 74104) and Proteinase K (Qiagen, cat N◦ 19131). The
isolated RNA was precipitated overnight at −20◦C using 0.3M
sodium acetate (pH 5.2) in Ethanol and washed in 70% Ethanol.
The dried RNA was resuspended in nuclease- free water (Fisher
Scientific, Loughborough, United Kingdom) and purity and
amount quantified using a spectrophotometer (at absorptions
of 280, 260, and 240 nm). 100 ng RNA was reverse-transcribed
using the OMNIscript Kit (Qiagen, cat N◦ 205110) with random
hexamers, following the manufacturer’s protocol. A volume
corresponding to 3 or 0.3 ng (for 28S) initial RNA was subjected
to real-time polymerase chain reaction (RT-PCR) with specific
primers for ACE and 28S, using Sybr Green master mix (Applied
Biosystems) on a Bio-Rad DNAmachine (MJ/Bio-Rad Chromo4;
Bio-Rad Laboratories, Watford, United Kingdom) controlled
by the MJ Opticon Monitor software (Bio-Rad Laboratories,
Watford, United Kingdom) based on the following protocol
(50 standard cycles 15 s 95◦C, 1min 55◦C, 15 s 75◦C). The
following primer sequences were used: ACE (5′-TCA CTA CGG
GGC CCA GCA CA-3′; 5′-TGC GCC CAC ATG TTC CCC
AG-3′). Primers were used according to established conditions
(Zoll et al., 2006) and designed with the online NCBI Primer-
Blast primer design tool (Rozen and Skaletsky, 2000) and
synthesized at Sigma-Genosys. Amplification was assessed by
a combination of analysis of melting curve and the cycle
threshold. For amplification to be deemed successful there must
have been a single clearly identifiable melting peak together
with a clear exponential increase (sigmoid curve) and plateau.
Transcript amounts were determined with the 1CT method,
taking individual efficiency of amplification into account. The
calculated values were standardized to the input amount of
cDNA, standardized to 28S and normalized to average values
prior to exercise.
ACE Activity in Skeletal Muscle
The analysis of ACE activity in muscle tissue was carried out
using a fluorometric assay as modified from the published
method of Sentandreu and Toldra (2006). In brief, 10 mm3
of biopsy material from vastus lateralis muscle was cross-
sectioned in a cryostat and homogenate was prepared in ice-cold
0.1M KH2PO4 buffer using a Polytron R©PT 1200E hand-held
homogenizer (Kinematica AG, Lucerne, Switzerland). Protein
concentration was determined using the BCA method (Pierce,
Rockford IL, USA) against BSA as a standard.
Total homogenate corresponding to 35 µg protein in 100
µl 0.1M KH2PO4 buffer was assessed by adding 200 µl of
solution containing 0.45mM of substrate o-aminobenzoylglycyl-
p-nitro-L-phenylalanyl-L-proline (Abz-Gly-Phe(NO2)-Pro; cat.
no. M-1100, Bachem, Bubendorf, Switzerland) and 1.125MNaCl
in 150mM Tris-base buffer (pH 8.3). Reactions were run in
duplicate for 4 h at 37◦C in the dark in a flat bottom OptiPlate
96 well microplate (cat. No.6005290, Perkin Elmer, Perkin Elmer,
Schwerzenbach, Switzerland). Fluorescence was measured using
a Multi-detection Microplate Reader (SynergyTM HT, BioTek
Instruments) at respective excitation and emission wavelengths
of 360 and 460 nm. The coefficient of variation of repeated
measures was 9%. The specificity of ACE-mediated substrate
cleavage was monitored in control reactions where 1µM
Lisinopril (Ratiopharm, Madrid-Spain) was added. This was
compared to signal of control incubations with 7.5 µg mL−1
of purified ACE enzyme (rabbit-lung, cat. no. A-6778; Sigma
Buchs Switzerland) in the presence or absence of Lisinopril 1µM.
Under these conditions 96 and 75% of substrate conversion by
the purified enzyme and total homogenate, respectively, was
blocked with Lisinopril. The signal was calibrated vs. the emission
of o-amino-benzoylglycine (Abz-Gly; Bachem cat. no. E-2920) as
titrated between concentrations of 1.5 and 20µM.
Serum Angiotensin 2 Concentration
Blood (2mL) was withdrawn from the venous cannula into
vacutainers containing 60 µl Angiotensin 2 inhibitor cocktail,
comprising 13.35 µl of O-Phenanthroline and Pepstatine A in
DMSO mixed with 46.65 µl of EDTA and PHMB in aqueous
solution (SPI bio, Bertin pharma, Versailles, France). The
samples were immediately centrifuged at 10,000 rpm (3,000 g)
and 4◦C for 12min. The supernatant was separated, snap frozen
in liquid nitrogen and stored at −80◦C until analyzed. Plasma
was extracted with C18 phenyl cartridge, which were conditioned
with 2mL of methanol and then rinsed with 2mL of water. Cold
plasma (0.9mL) was rapidly passed through the cartridge and
subsequently washed with 1mL of water. Absorbed angiotensins
were eluted with 1mL of methanol into conical polypropylene
tubes. The eluate was evaporated to dryness by means of a
nitrogen gas stream at room temperature and the residue was
stored at−20◦C. Angiotensin 2 was assessed with the angiotensin
2 enzyme immunoassay kit (SpiBio, Montigny Le Bretonneux,
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France). Briefly, the plasma samples were incubated for 1 h with
100µl of EIA buffer (reconstituted the EIA buffer vial with 50mL
of distilled water), for 5min with 50 µl of glutaraldehyde (100
µl of gluteraldehyde diluted in 0.125mL of concentrated Wash
buffer and 4.878mL of distilled water), for 5min with 100 µl
of borane-trimethylamine (borane-trimethylamine vial diluted in
2.5mL of 2NHCL and 2.5mL of methanol) on a rocker platform,
and with 100 µl of anti-angiotensin 2 IgG tracer (reconstituted
the anti-antiotensin II-IgG tracer in 10 mL of EIA buffer) at
4◦ overnight. On the next day the samples were incubated with
200 µl of Ellman’s reagent (Ellman’s reagent vial in 1mL of
concentratedWash buffer and 29mL of distilled water). The plate
was run with a single quick read on an Absorbance Microplate
Reader (ELx800, BIO-TEK) with wavelength 405 after 30min, 1
and 2 h of incubation.
After plotting the absorbance of each standard point vs. the
concentration, the angiotensin 2 concentrations were calculated
by interpolating from this standard curve. In order to reduce
variability, angiotensin 2 values were normalized to the median
of the pre-values.
VEGF and Tenascin-C Protein Expression
in Skeletal Muscle
Total protein homogenate was prepared from the biopsy
material, and subjected to SDS-PAGE and immunoblotting for
tenascin-C and VEGF essentially as previously described (Flück
et al., 2008; van Ginkel et al., 2016).
In brief, 5 mm3 of muscle tissue was extracted with a
Polytron R©PT 1200E hand-held homogenizer (Kinematica
AG, Lucerne, Switzerland) from cross-sectioned 25-µm-thick
cryo-sections into ice-cold RIPA buffer that included 10mM
Tris-HCl (pH 7.5), 150mM NaCl, 1mM EDTA, 1% NP-40, 2%
Triton X100, 2mM EDTA, 2mM EGTA, one PhosStop tablet,
and complete-mini EDTA-Free reagent (Roche Diagnostics
GmbH, Mannheim, Germany). Protein concentration in the
total homogenate was determined using the BCA method
(Pierce, Rockford IL, USA) and adjusted to a concentration of
2 µg µL−1 using Laemmli buffer (Bio-Rad Laboratories AG,
Cressier, Switzerland) including 2% mercaptoethanol. Samples
were denatured for 5min at 95◦C and a volume corresponding
to 10 µg of total protein from pre/post sample pairs was
separated by 7.5% SDS-PAGE using precast gels (Bio-Rad
Mini-protean TGX Stain-free). Proteins were blotted onto a
nitrocellulose membrane with a Trans-blot-Turbo Transfer
System (Bio-Rad AG, Cressier, Switzerland) and stained with
Ponceau S to record protein loading based on the stained actin
band at ∼43 kDa. Subsequently the membrane was subjected
to immunodetection with specific primary antibody against
VEGFA (monoclonal antibody 26503; Abcam, Cambridge,
United Kingdom) or tenascin-C (monoclonal antibody B28.13, a
gift from Prof. Matthias Chiquet); and appropriate horse-radish
peroxidase-conjugated secondary antibody in 5%-milk/10%
BSA –TTBS (anti-mouse IgG raised in goat, A-2304, Sigma
Buchs Switzerland). Signal was recorded with enhanced
chemoluminescence (Supersignal West Femto, Fisher Scientific
AG, Wohlen, Switzerland) using a PXi System (Syngene). Band
signal intensity was estimated using the Quantity One software
(Bio-Rad, Life Science Research, Hercules, CA, USA) with the
“volume rectangular tool” and were corrected vs. the background
of a band of equal height and size (area) from an empty sample
lane. Background-corrected data were normalized to actin, and
then normalized to the mean values of the pre-training sample
from the same gel. Therefore, the final values reflect the relative
expression levels per total muscle protein.
Immunohistological Detection of
Tenascin-C Protein
Cryo-sections were prepared from vastus lateralis muscle,
and subjected to immunological staining for VEGFA or
tenascin-C using the MA3 antibody essentially as previously
described (Flück et al., 2003). Nuclei were counterstained with
hematoxylin.
Muscle Glycogen
Glycogen was measured relative to the total amount of muscle
protein essentially as described previously (Vaughan et al., 2016).
In brief, cryo-sections (25µm) were prepared from muscle
biopsies and the section volume estimated from microscopic
measures of the CSA and the height of the sectioned tissue.
An approximate of 1 mm3 tissue was homogenized in 100
µl of a PBS/inhibitor-cocktail [1mL PBS + 9mL dH2O +
1 complete Mini, EDTA-free tablet (Sigma Aldrich, Buchs,
Switzerland) in a 1.5mL Eppendorf tube by using a steel pistil
(Behrens-Labortechnik, Germany). Total protein content was
assessed using the Pierce BCA Protein Assay Kit (Thermo
Scientific, Town, USA) and quantified at 562 nm on a 96-well
plate with a Synergy HT spectrometer (BioTek Instruments
Inc., Vermont USA). Glycogen was measured on 20 µl muscle
homogenate against a glycogen standard with the Assay Kit
(abcam, Cambridge, UK) according to the instructions. Signal
was detected at 564 nm using a Synergy HT spectrometer
(BioTek, Lucerne, Switzerland).
Muscle Metabolites
Metabolite profiles of biopsy samples, collected before
and 30-min after one leg exercise were determined using
ultrahigh performance liquid chromatography—tandem mass
spectrometry (UPLC–MS) based on an established protocol
(Vaughan et al., 2016). In brief, 5mg muscle tissue was extracted
in cold MetOH: MTBE: H20 = 360: 1,200: 348 using a full
glass Potter type homogenizer. 10 µL of a 50-µM solution
of each LysoPC (17:0) (Avanti Polar Lipids) and 13C-Sorbitol
(Sigma) was added as internal standards. The non-polar and
polar phase was separately recovered and stored at −30◦C
before being dried down under a steam of nitrogen and being
reconstituted. For polar metabolites, this was 100 µL of 50mM
ammoniumacetate in acetonitrile – water 9:1 (v/v); for non-
polar lipids, this was 100 uL of 10mM ammonium acetate in
80% aqueous methanol. All extraction steps were carried out
in dichlormethane-rinsed Duran glassware using MS-Grade
compounds (CHROMOSOLV R©, Sigma). All solvents used were
of quality HPLC grade (Chromasolv, Sigma-Aldrich, Buchs,
Switzerland).
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Subsequently 1 µL of sample was injected (twice) at a
flow of 3 µL min−1 into the UPLC-MS. Metabolites were
separated on nanoAquity UPLC (Waters) equipped with a BEH-
Amide capillary column (200µm × 150mm, 1.7µm particle
size, Waters), applying a gradient of 0.5µM ammoniumacetate
in acetonitril (A) and 0.5µM ammoniumacetate in water
(B) from 90 to 50% A. The UPLC was coupled to Q
ExactiveTM Hybrid Quadrupole-Orbitrap Mass Spectrometer
(Thermo Fisher Scientific, Reinach, Switzerland) by a nanoESI
source. MS data was acquired using negative polarization and all
ion fragmentation (AIF) over a mass range of 80 to 1,200 m/z at
a resolution of 70,000 (MS) and 25,000 (MSMS).
Lipid compounds were separated on nanoAquity UPLC
(Waters) equipped with a C18 reversed phase column (HSS
T3 1.7 microns, 0.2 × 50mm, Waters) applying a gradient
of 5 uM ammoniumacetate in acetonitril—water 40:60 v/v
(A) and 5 uM ammoniumacetate in acetonitrile—isopropanol
10:90 v/v (B) from 95 to 2% A. The UPLC was coupled to a
Q ExactiveTM Hybrid Quadrupole-Orbitrap Mass Spectrometer
(Thermo Fisher) by a nanoESI source that was operated in
positive polarization mode, applying a voltage of 1.8 kV. The
MS was operated in data independent acquisition mode (All
Ion Fragmentation) with stepped collision energy setting (CE
30-35-40V).
Mass spectrometry data sets were processed with Progenesis
QI (Nonlinear Dynamics, A Waters Company) which aligns
the ion intensity maps based on a reference data set, followed
by a peak picking on an aggregated ion intensity map.
Compound ions were detected and quantified by a multi-
step procedure including the retention time (RT) alignment
of observed m/z signals, the construction of a consensus
m/z–RT map, grouping of co-eluting adducts with the major
ions and quantification of detected compounds through all
samples. Detected compound ions were further annotated by
database searches based on derived neutral masses, isotopic
patterns and the match of observed fragmentation spectra and
theoretical fragmentation spectra. Database searches were run
with a tolerance of 50 mD and included LipidMaps (www.
lipidmaps.org) and the Human Metabolome Data Base (HMDB,
www.hmdb.ca). Fragmentation patterns were not considered for
the identifications. Compounds, which demonstrated significant
differences (see paragraph “statistics” below), were allocated its
respective HMDB or Pubchem substance identifier (SID).
Quality controls were run on individual and mixed samples to
determine technical accuracy based on 20 selected compounds
(amino acids, nucleotides, and metabolic intermediates) in
mixed samples using Quan Browser (Xcalibur, Thermo Fisher
Scientific) and 61 further abundant ions using Progenesis QI
software (Nonlinear Dynamics). The coefficients of variation for
biological and technical replicas of the 20 compounds in mixing
experiments demonstrated values near or below 20%. Biological
replicas correlated to an r-value of 0.72.
Statistics
Data were organized in MS-Excel (Microsoft Office Professional
Plus 10, Kildare, Ireland) and exported into SPSS 19.0 for
statistical testing (version 23, IBM). Data were processed
for display using Prism software (Graphpad Software Inc).
Compliance with the Hardy-Weinberg equilibrium was assessed
using an online calculator, i.e., https://www.cog-genomics.org/
software/stats.
For performance, muscle composition and angiogenic
parameters, effects of training status and genotype at rest and
fold changes with exercise were calculated based on univariate
ANOVAs for the factor training status (untrained, trained) and
genotype. For the latter, the effect of the ACE_I/D genotype
(ACE-DD, ACE-ID, ACE-II) or the effect of carrying the ACE
I-allele [i.e., carriers (ACE-II or ACE-ID) vs. non-carriers
(ACE-DD genotypes)] were assessed separately. The effect of
exercise was assessed with a repeated ANOVA for the factor of
exercise (pre, post). Fisher’s post-hoc test was chosen to localize
differences post hoc. Significance of a difference was declared at p
< 0.05. Multiplicity error was controlled based on false discovery
rate as proposed by Benjamini and Hochberg (Benjamini and
Hochberg, 1995). Linear relationships were calculated based
on Pearson correlations and called significant at p < 0.05.
Association between training status and age were calculated
based on Chi2-tests.
For the metabolomic analysis, data mining, subsequent
analysis, and table assembly, was conducted in MS-Excel.
Alterations in ion abundance were calculated only for those
compounds that were detected in all analyzed samples. Signals
were normalized to the summed abundance of all ions being
detected in one given sample. For each sample, raw signals
of each compound were related to the internal standard as
generated by the Progenesis QI software. For multiply detected
metabolite species, the average signal was calculated and used
for the further analysis. Exercise induced changes were assessed
based on permutations of T-tests using Significance Analysis
of Microarrays test (SAM) running as an applet in MS-Excel
software (Tusher et al., 2001) from a paired class comparison
between the values from pre and 30-min post samples. A false
discovery rate of 5% was deemed significant. Subsequently,
compounds were identified which demonstrated an influence of
the ACE-I allele in either training state (trained or untrained)
based on T-tests. Affected metabolite and lipid compounds
were subjected to supervised cluster analysis and displayed with
Treeview as described previously (Valdivieso et al., 2017).
RESULTS
Cell Physiological Characteristics of the
Subjects in Relation to Training State
Twenty-eight of the 52 studied subjects classified to the criteria of
being endurance-trained; the other 24 subjects being classified as
untrained. Table 1 summarizes the physiological characteristics
of the subjects in dependence of the training status. Trained
subjects had less body fat (14.2 vs. 22.2%) and more fat-free-mass
(64.6 vs. 59.8 kg) than the untrained subjects (Table 1). Training
status influenced performance related parameters of endurance
performance (Figure 1). This comprised a 23.1% higher peak
aerobic power (PPO), and 20.3% higher absolute peak oxygen
uptake (V˙O2peak), respectively. There was a trend for a larger
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TABLE 1 | Subject characteristics.
untrained or trained (n = 52) Untrained (n = 24) trained (n = 28) p-value
Age (years) 28.1 ± 0.9 (19.0–38.0) 26.3 ± 1.14 (19.0–37.4) 28.1 ± 1.2 (19.0–38.0) 0.2605
Mass (kg) 77.6 ± 1.6 (58.3–99.0) 77.7 ± 2.41 (59.7–99.0) 79.9 ± 2.4 (58.3–99.0) 0.5194
Height (cm) 180.3 ± 1.6 (155.7–204.4) 180.9 ± 2.72 (158.4–204.4) 181.7 ± 0.0 (1.6–2.0) 0.8391
BMI (kg m−2 ) 23.9 ± 0.5 (18.5–30.9) 24.0 ± 0.73 (18.5–30.9) 24.1 ± 0.7 (19.4–29.6) 0.9330
Body fat (%) 17.3 ± 1.1 (6.0–32.1) 22.2 ± 6.92 (10.7–32.1) 14.2 ± 1.3 (6.0–28.0) 0.0030
Fat-free- mass (kg) 64.6 ± 1.3 (48.5–79.6) 59.8 ± 1.6 (48.5–71.6) 64.6 ± 1.2 (58.7–79.6) 0.0004
Systolic BP (mm Hg) 123.8 ± 1.6 (104.9–148.0) 124.0 ± 2.27 (104.9–134.3) 125.3 ± 2.2 (113.1–148.0) 0.6785
Diastolic BP (mm Hg) 74.3 ± 1.3 (62.3–92.0) 74.0 ± 2.10 (63.7–83.5) 75.3 ± 2.0 (62.3–92.0) 0.6664
PPO (Watt) 315.8 ± 8.4 (229.5–467.5) 293.4 ± 11.35 (229.5–387.6) 361.1 ± 11.6 (252.0–467.5) 0.0001
V˙O2peak (mL O2 min−1 ) 4107.5 ± 102.3 (2983.5–5816.8) 3815.7 ± 148.89 (2983.5–5102.9) 4589.3 ± 152.4 (3315.0–5816.8) 0.0008
V˙O2peakr (mL O2 min−1 kg−1) 53.8 ± 1.2 (38.7–72.7) 48.8 ± 1.70 (38.7–61.4) 59.5 ± 1.7 (49.9–72.7) 0.0001
RERrest (V˙CO2/V˙ O2) 0.77 ± 0.01 (0.58–0.99) 0.77 ± 0.02 (0.58–0.99) 0.72 ± 0.03 (0.63–0.89) 0.2156
RERpeak (V˙CO2/V˙ O2) 1.11 ± 0.02 (0.84–1.32) 1.10 ± 0.03 (0.84–1.32) 1.07 ± 0.19 (0.97–1.30) 0.6640
Values represent mean ± SE of values (minima-maxima) of the studied subjects combined (n = 52) and split for endurance training status (trained n = 28; untrained n = 24). P-values
refer to the significance of differences between the trained and untrained group (univariate ANOVA for ACE-I/D allele × training status as a factor). Underlined p-values denote those
differences, which passed the threshold of a false discovery rate of 5%. BMI, body mass index; BP, blood pressure; PPO, peak power output (during two-legged exercise); RERpeak,
peak respiration exchange ratio during two-legged exercise; RERrest, respiration exchange ratio at rest before two-legged exercise; V˙O2peak, peak oxygen uptake (during two-legged
exercise); V˙O2peakr, body mass-related peak oxygen uptake during two-legged exercise.
FIGURE 1 | Significance map of training × genotype interactions for parameters of muscle-powered endurance exercise. Visualization of the p-values for the
indicated effects for the anthropometric, physiological and muscle data of the studied subjects (untrained: 11xACE-DD, 10xACE-ID, 3xACE-II; trained: 15xACE-DD,
10xACE-ID, 3xACE-II) before exercise based on univariate ANOVAs. Black rectangles indicate those effects, which passed the 5% threshold of statistical significance
Underlined font highlights parameters, which demonstrated an interaction effect between “training status” × “genotype.” PArea TypeI, percentage of the muscle
biopsy CSA being composed of type I muscle fibers; PTypeI, percentage of type I muscle fibers.
CSA of the quadriceps group in the trained compared to
untrained subjects (p= 0.051; 2319.9 vs. 2013.6 mm2; Table S2).
MCSAs of type I (+36.2%) and type II (+27.2%) muscle fibers,
and capillary-to-fiber ratio (+27.3%) in m. vastus lateralis were
larger in the trained than the untrained subjects (Table S2).
ACE-I/D Genotype-Associated Exercise
Performance
Hardy-Weinberg equilibrium was met in the 52 studied subjects
(i.e., p = 0.483). ACE-I/D genotype effects were seen for systolic
blood pressure at rest, PPO, and FPPO (Figure 1, Table S1).
I-allele carriers developed 11%more PPO than non-carriers (p=
0.014). At the post hoc level, PPO during two-legged exercise (p
= 0.014), and PPO1 during one-legged exercise (p= 0.040), were
both 19% higher in ACE-II than ACE-DD genotypes. In trained
subjects PPO during two-legged exercise remained 14% higher in
ACE-II thanACE-DD genotypes (Table S1). An interaction effect
of the ACE-I/D genotype and training status was identified for
RERpeak (Table S1).
Training Status and ACE-I/D
Genotype-Associated Muscle Parameters
Genotype effects were seen for the composition of vastus lateralis
muscle, including capillary density and capillary-to-fiber ratio,
MCSA of type I and II muscle fibers (Figure 1, Table S2). The
muscle CSA andMCSA for type I muscle fibers, the percentage of
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type I fibers and the area percentage of type I muscle fibers in the
middle portion ofm. vastus lateralis, demonstrated an interaction
effect between training state × ACE-I/D genotype (Table S2).
Untrained carriers of the ACE I-allele had a 22.6% larger CSA
than untrained non-carriers of the ACE I-allele (i.e., ACE-DD
genotypes; p = 0.040). Trained I-allele carriers demonstrated a
38.8% larger MCSAs of type I muscle fibers than trained non-
carriers of the I-allele (Figures 2A,B). Capillary-to-fiber ratio and
capillary density were elevated in ACE I-allele compared to non-
I-allele carriers of the ACE gene irrespective of the training state
(Table S2, Figures 3A,B).
One-Legged Exercise Stimulus
Table 2 shows the physiological characteristics of the subjects
during the one-legged exercise stimulus on the cycle ergometer in
dependence of the training state. During the one-legged exercise,
trained subjects performed at an 8% lower fraction of two-legged
V˙O2peak (FV˙O2peak) than the untrained individuals. One-
legged cycling exercise increased RER by 15% in the untrained
subjects and 13% in the trained subjects, relative to pre-values.
Training State Influences the ACE-I/D
Genotype Modulated Angiogenic
Response to Exercise
VEGFA protein was detected as a monomer and dimer at 23 and
46-kDa, respectively (Figure 4). Tenascin-C protein was detected
mainly as the 230-kDa isoform (Figure 4).
At rest, prior to exercise VEGFA protein levels in m. vastus
lateralis were higher in carriers of the ACE I-allele than non-
carriers, irrespective of whether subjects were untrained (+92%)
or trained (+90%; Table S2). VEGFA protein levels were 13%
reduced 30-min after one-legged exercise and this response was
affected by the ACE I-allele (p = 0.003), but not the training
status (p = 0.181; Figures 4C,D). The effect was explained by a
reduction in VEGFA protein levels in non-carriers of the ACE I-
allele compared to the I-allele carriers (−22 vs.−6%; Figure 4D).
Tenascin-C protein levels at rest were not affected by training
status (p = 0.243) and ACE-I/D genotype (p = 0.846) and I-
allele (p = 0.536) prior to exercise. Exercise-induced alterations
in tenascin-C levels demonstrated an effect of training status (p
= 0.002) and trend for effect of the ACE-I-allele (p = 0.050) and
trend for an interaction effect of training status × ACE I-allele
(p = 0.064; Figure 4F). In untrained non-carriers of the I-allele
(i.e., ACE-DD) tenascin-C protein levels were 30% decreased
post exercise, whereas trained ACE-DD genotypes demonstrated
47% elevated tenascin-C levels post exercise.
ACE-I/D Genotype Modifies the Local ACE
System
Prior to one-legged exercise, serum angiotensin 2 levels were
238% higher, in non-carriers than carriers of the ACE I-allele
(p = 0.003, data not shown). ACE transcript levels in vastus
lateralis muscle prior to exercise demonstrated an interaction
effect between ACE-I/D genotype and training status (Table S2).
Untrained non-carriers of the ACE I-allele showed 38% higher
ACE transcript levels than the respective I-allele carriers whereas
trained non-carriers of the ACE I-allele showed 70% lower ACE
transcript levels than I-allele carriers. ACE activity in muscle
tissue prior to exercise did not differ dependent on ACE-I/D
genotype (p = 0.569), the I-allele (p = 0.929) and training status
(p= 0.286).
One-legged exercise affected ACE transcript expression 8-h
post exercise. Exercise-induced fold changes in ACE transcript
levels demonstrated an effect of training state (p = 0.031),
ACE-I/D genotype (0.017) and an interaction effect between
genotype × training status (p = 0.003; Figure 5). The effect
was explained by a selective increased ACE transcript levels
in trained homozygous I allele carriers (i.e., ACE-II genotypes;
Figure 5).
Training State Influences the ACE-I/D
Genotype Modulated Metabolic Response
to Exhaustive Exercise
We explored the acute metabolic effects of one-legged exercise
in a subset of subjects (i.e., 8 untrained and 14 endurance-
trained subject). At rest before exercise, glycogen concentration
demonstrated an ACE-I/D genotype× training status interaction
(Table S2), i.e., for the untrained subjects being 0.05 mg/mg
higher in the ACE-DD than ACE-II genotypes, while for the
trained subjects being 0.06 mg/mg lower in ACE-DD than
the ACE-II genotypes. Glycogen concentration was reduced
30-min after the one-legged exercise in both untrained and
trained subjects. The exercise-induced fold changes in glycogen
concentration depended on the ACE-I/D genotype (p = 0.010)
but not the training status (p = 0.677). Post exercise glycogen
concentration was 42% and 36% more reduced in ACE-ID and
ACE-DD than ACE-II genotypes, respectively (Figure 6).
Metabolomic profiling identified 924 polar metabolites and
2467 non-polar metabolites (i.e., lipids) in vastus lateralismuscle.
At rest, the levels of 455 metabolite species differed between
trained and untrained subjects, 122 of which were identified.
121 annotated metabolites, comprising prominent metabolites
such as acetyl-CoA, carbonic acid, dGTP, D-Mannose, glycerol
3-phosphate, L-aspartic acid, L-glutamic acid, and glutathione,
were increasingly abundant in trained subjects (Table S3). One
metabolite, 2-methyl-3-pentenoic acid (HMDB31562), was less
abundant inm. vastus lateralis of the trained subjects. 879 lipidic
compounds were less abundant in the m. vasti of the trained
compared to the untrained subjects, 29 of which were annotated
(Table S3). 13 metabolites and 13 non-polar lipids demonstrated
an exercise response (Tables S4, S5). 59 metabolites, including 24
uniquely annotated species, and 780 non-polar lipids, including
13 annotated species, demonstrated an exercise response, which
varied between ACE I-allele carriers in the trained subjects,
and/or untrained subjects (Figure 7, Table 3). Thereby the I-
allele related response of lipid compounds post exercise in
untrained subjects was inversed in the trained subjects.
Interrelationships
Anumber of relationships were identified between characteristics
of muscle composition and performance during one- and
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FIGURE 2 | Effect of ACE-I/D genotype on muscle fiber structure. Scatter dot plot of the individual values and means (horizontal lines) of mean cross-sectional area
(MCSA) of type I and II muscle fibers (A,B), distribution (C) and area percentage (D) of type I muscle fibers for the 52 studied subjects when split for ACE-I/D genotype
(26xACE-DD, 20xACE-ID, 6xACE-II). Filled and non-filled symbols in A, B indicate values of the trained and untrained subjects, respectively. * and ** denote p < 0.05
and p < 0.01 vs. ACE-DD. Univariate ANOVA with post hoc test of Fisher. Only genotype effects are indicated.
FIGURE 3 | Effect of ACE-I/D genotype on muscle capillarisation. Scatter dot plot of the individual values and means of capillary density (A) and capillary to fiber ratio
(B) for the 52 studied subjects when split for ACE-I/D genotype (26xACE-DD, 20xACE-ID, 6xACE-II). Filled and non-filled symbols in (A,B) indicate values of the
trained and untrained subjects, respectively. * denotes *p < 0.05 vs. ACE-DD; **p < 0.01 vs. ACE-DD. Univariate ANOVA with post hoc test of Fisher. Only genotype
effects are indicated.
two-legged exercise (Figure S1). Peak power output (PPO)
during two- and one-legged exercise correlated to CSA of m.
vastus lateralis (r= 0.51, r= 0.44) and quadriceps CSA (r= 0.64,
r = 0.59), MCSA of type I (r = 0.65, r = 0.54) and MCSA of type
II muscle fibers (r= 0.51, r= 0.46), and capillary-to-fiber-ratio (r
= 0.43, r = 0.46). Serum angiotensin 2 concentrations correlated
with ACE transcript levels, expression levels of the angiogenic
proteins VEGFA and tenascin-C, glycogen concentration and
capillary density (Table S6). ACE transcript expression in m.
vastus lateralis was negatively correlated to angiotensin 2 levels
(r =−0.92) and positively correlated to mean CSA of type I (r =
0.55) and type II muscle fibers (r = 0.69).
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TABLE 2 | Physiological characteristics of trained and untrained subjects during one-legged exercise.
Factor untrained or trained (n = 52) untrained (n = 24) trained (n = 28)
Mean ± SD Mean ± SD Mean ± SD p-value
PPO1 (W) 190.8 ± 41.6 177.8 ± 38.3 221.1 ± 43.7 0.0011
V˙O2peak1 (mLO2 min−1 ) 3425.7 ± 630.8 3352.7 ± 672.3 3678.4 ± 765.6 0.1409
V˙O2peakr1 (mLO2 min−1 kg−1) 43.5 ± 5.3 43.2 ± 5.4 45.8 ± 6.2 0.1478
FPPO (fraction) 0.60 ± 0.07 0.60 ± 0.06 0.61 ± 0.07 0.8667
FV˙O2peak (fraction) 0.83 ± 0.09 0.88 ± 0.09 0.81 ± 0.10 0.0143
RERrest1 (V˙CO2/V˙O2) 0.81 ± 0.17 0.79 ± 0.13 0.82 ± 0.16 0.5755
RERpeak1 (V˙CO2/V˙O2) 0.92 ± 0.10 0.91 ± 0.09 0.93 ± 0.11 0.5792
Values represent mean ± SD of baseline (i.e., pre) values of the studied subjects combined (n = 52) and split for endurance trained (n = 28) and untrained (n = 24) status. P-values refer
to the significance of differences between the trained and untrained group (univariate ANOVA for ACE-I/D allele x training status as a factor) with values that passed a false discovery
rate of 5% being underlined. PPO1, peak power output during one-legged exercise; FPPO, fraction of PPO at which the one-legged exercise was performed; FV˙O2peak, fraction of
V˙O2peak at which the one-legged exercise was performed; RERpeak1, peak respiration exchange ratio during one-legged exercise; RERrest1, respiration exchange ratio before the
one-legged exercise; V˙O2peak1, peak oxygen uptake during one-legged exercise; V˙O2peakr1, body mass-related peak oxygen uptake during one-legged exercise.
DISCUSSION
The renin-angiotensin-aldosterone-system exerts an important
role in systemic regulation of blood circulation and blood
pressure. Despite paucity for a role in modifying metabolic
function and performance of muscle during exercise (Dietze and
Henriksen, 2008; Vaughan et al., 2016), this system has not been
well characterized at the tissue level during exercise. Substrate
delivery and angiogenic factor regulation in exercising muscle
are strong candidates for the processes driving local effects of
angiotensin with exercise, because the capillary tree becomes
increasingly perfused with the onset of contraction (Clifford and
Hellsten, 2004; Korthuis, 2011), which may trigger the release
of vasoactive and pro-angiogenic factors (such as VEGFA) from
the mechanically sheared endothelial wall of perfused blood
vessels (Hoier et al., 2013). However, the former processes
may be importantly affected by the training status of subjects,
because repeated exercise improves the capacity for muscle
perfusion through an enhanced capacity for exercise-induced
vasodilatation and an increase of the capillary bed (Flück
and Hoppeler, 2003; Clifford and Hellsten, 2004; Mortensen
et al., 2014). Our previous studies associated the ACE-I allele
through a reduction in angiotensin production, with increased
capillarisation and improved aerobic substrate pathways with
endurance training (Vaughan et al., 2013, 2016). Here we assessed
the influence of the prominent insertion/deletion polymorphism
in the ACE gene, which entails the production of angiotensin
2 peptide, on muscle composition, capillarisation, metabolites
and performance with specific regard on the influence of
the training state. Because training typically elevates the
capacity for perfusion through an increase in capillarisation and
vasodilatation (Flück and Hoppeler, 2003; Clifford and Hellsten,
2004) we hypothesized that training modifies the reported
influence of the insertion allele on exercise-induced reactions
of metabolites, which are consumed during contraction, muscle
capillarisation and expression of pro-angiogenic factors (Flueck
et al., 2010; Vaughan et al., 2013, 2016) which explain differences
in peak aerobic performance at baseline and with training.
Our genetical approach exposes distinct interaction effects of
the ACE-I/D genotype and training status regarding exercise-
induced alterations of metabolites, the expression of the pro-
angiogenic factors VEGFA and tenascin-C, ACE transcript levels,
and (fiber) CSAs in m. vastus lateralis. By contrast muscle
capillarisation in the same muscle and systolic blood pressure,
and aerobic power of untrained subjects, were elevated in
ACE I-allele carriers, which outweighed the influence of the
training state. The observed dependencies, in a muscle being
frequently recruited during endurance exercise, highlight a role
for genetically modified angiotensin production in metabolic
regulation of contracting muscle and the subsequently regulation
of “metabolic” plasticity of muscle during recovery from repeated
bouts of exercise.
Systemic Relationships
Because the ACE genotype affects systemic aspects of exercise
(Hernández et al., 2003), which may be differently influenced by
the ACE-I/D genotype, we selected a one-legged exercise stimulus
to avoid central limitations in substrate supply to workingmuscle
when exercising at high intensity. Notably, the validity of this
assumption has been put into evidence post-hoc put based on
the effect of the ACE-I/D genotype on systolic blood pressure
(Table S1). The selected one-legged exercise intervention also
allowed maximizing the metabolic stimulus for recruited muscle
groups. Because perfusion-related events show a rapid onset
(Clifford and Hellsten, 2004) we assessed level alterations in
VEGFA and tenascin-C protein and muscle metabolites 30min
after exhaustive endurance exercise. Interestingly we identify that
non-carriers of the ACE I-allele produced peak power during
the one-legged exercise at an elevated fraction of peak aerobic
power output as determined during two-legged exercise (i.e., 0.62
vs. 0.58 with a p-value of 0.03; see FPPO in Table S1). This
difference possibly reflects that the deployed one-leg intervention
weighs muscle aspects more than central aspects for power
production during cycling type leg endurance exercise. This view
is supported by the positive influence of the ACE I-allele and
training on the MCSA of type I and II fibers, and capillary-to-
fiber ratio in the studied knee extensor muscle. The higher FPPO
in ACE-DD genotypes suggest that this genotype demonstrated
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FIGURE 4 | Effect of ACE-I/D genotype and training status on pro-angiogenic protein levels in vastus lateralis muscle. Examples of the detection of tenascin-C and
VEGFA expression in vastus lateralis muscle pre- and post-exercise in homogenates of untrained and trained ACE-DD and ACE-II genotypes (A,B). Actin loading
(Continued)
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FIGURE 4 | controls are shown below. C–F) Box-and-whisker plot of median fold changes in VEGFA (C,D) and Tenascin-C (E,F) 30-min post exercise vs. pre- for
the 52 studied subjects when split for ACE-I/D genotype (C,E; 26xACE-DD, 20xACE-ID, 6xACE-II) or training state and the presence of the ACE I-allele (D, F;
untrained: untrained: 11xACE-DD, 10xACE-ID, 3xACE-II; trained: 15xACE-DD, 10xACE-ID, 3xACE-II). The lines denote the median, the box delimits the quartiles and
the whiskers denote the farthest points that are not outliers.
†
p < 0.05 vs. pre; $p < 0.05 vs. same genotype untrained; * and ** denote p < 0.05 and p< 0.01 vs.
ACE-DD (no I-allele), respectively. Univariate ANOVA with post hoc test of Fisher. Only genotype effects are indicated.
FIGURE 5 | Effect of ACE-I/D genotype and training status on ACE transcript
expression post exercise. Box-and-whisker plot of fold alterations in ACE
transcript levels between the trained and untrained subjects, 8 h post- vs.
pre-exercise, in each ACE-I/D genotype. *p < 0.05 for the indicated
comparison. ACE-II. Univariate ANOVA with post hoc test of Fisher.
a certain degree of central “handicap” to allocate resources
for muscle-based production of power output under aerobic
conditions as previously discussed (Hernández et al., 2003).
The untrained rather than the trained ACE-I-allele carriers,
i.e., p = 0.005 vs. p = 0.744, demonstrated a difference
in FPPO between I-allele carriers during two-legged exercise
and a trend for an interaction effect between training state
and I-allele was seen for FPPO (p = 0.089; Table S1). This
indicates that local mechanisms were more taxed in the
studied non-carriers of the ACE I-allele during extensive
exercise and that this influence depended on the training state.
Several local muscle mechanisms (including the higher MCSA
and capillarisation of muscle fibers (Table S2, Figure 2) may
contribute to this elevated aerobic performance. For instance
ACE-I-allele dependent differences in the adjustments of the
volume density of mitochondria and intramyocellular lipid
stores in muscle fibers with endurance training (Vaughan et al.,
2013), may contribute to the observed interaction between
training state and I-allele for FPPO. Our findings now show
that muscle parameters which influence endurance performance
FIGURE 6 | Effect of ACE-I/D genotype on glycogen depletion post exercise.
Box-and-whisker plot of fold alterations in glycogen concentration in the
studied subjects, 30-min post vs. pre-exercise, in each ACE-I/D genotype. *p
< 0.05 vs. ACE-II. Univariate ANOVA with post hoc test of Fisher.
with training are already favorably affected by the ACE-I-
allele. For instance, glycogen concentration was to a larger
degree reduced post exercise in D-allele carriers irrespective
to training state whereas muscle capillarisation was higher in
ACE I-allele carriers (Table S2, Figures 3A,B, 6). Consistently
with the former, we identify that trained ACE-DD genotypes
demonstrated a 55 µg mg-1 lower glycogen concentration
in m. vastus lateralis than the trained ACE-II genotypes,
probable reflecting the higher reliance on glycogen during
endurance exercise and handicap in the replenishment of these
intramyofibrillar carbohydrate stores in ACE-DD genotypes
(Vaughan et al., 2016).
A suspicious finding was that rather a small number of
metabolite compounds were affected 30-min post exercise when
genotype and training status were not considered (Tables S4,
S5). Amongst the affected compounds were few that deserve
a discussion. For instance, 2-keto glutaramic acid, which is a
(neuro)toxic metabolite of transamination reactions involving L-
glutamine (Cooper and Kuhara, 2014). It constitutes a critical
component of nitrogen metabolism and is detoxified in a
reaction with H2O to yield oxoglutaric acid (or alpha-keto
glutarate), the latter of which is involved in the regulation of
protein synthesis (Sahai et al., 1991; Cai et al., 2016). Other
exercise-regulated compounds were part of foods, alcohols or
medication (Tables S4, S5), including some which reflected
antibiotic or anticancer treatment, raising the question whether
certain subjects did violate the inclusion criteria.
Overall an important interaction effect between the ACE-I/D
genotype and the training state was identified for RERpeak and
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FIGURE 7 | Profiling for ACE-I/D × training dependent metabolites post exercise. Cluster analysis of linear relationships between 59 altered metabolite compounds
(A) and 780 altered non-polar (lipid) species (B) in a subset of subjects (7 untrained and 15 endurance-trained) 30-min post- vs. pre-exercise. Alterations in levels are
given in color code (up: red, down: blue) with the scale being indicated to top of each panel. On top the data are labeled by genotype (II, ID; DD) and training status (T,
trained; UT, untrained) and subject number. To the right, the compound IDs are indicated according to the human metabolome data base (HMDB). Dendrograms to
the left indicates the correlations between compounds. Lines separate profiles according to the I-allele. Unique and identified compound were subsequently identified.
Note: A clearly distinguishable pattern of alterations in lipid levels is evident for the trained vs. untrained subjects with the ACE-DD genotype.
the concentration of muscle metabolites and lipids, and glycogen
30-min after one-legged exercise. Twenty-four metabolites were
identified, which alterations post exercise varied between the
trained and untrained subjects in dependence of the ACE I-allele
(Figure 7A, Table 3). This included dCMP and FAD, that exert a
critical function in cell metabolism and the monoacylglycerides
MG(0:0/14:0/0:0) and MG(0:0/15:0/0:0). In this respect, we
measured a sizeable number of lipid compounds (i.e., 780),
which demonstrated an exercise response that varied between I-
allele carriers and training states. Figure 6B illustrates that the
regulated compounds strongly differentiated between untrained
and trained subjects not carrying the ACE I-allele. Notably
there was an important inversion of compound regulation in
ACE-DD genotypes. Thirteen of these non-polar compounds
were identified as prominent lipid species comprising 7 fatty
acyls, two sterols, a glycerolipid and a glycerophospholipid
(Table 3). The latter observations relate to identified ACE-
I/D dependent expressional regulation of lipid metabolizing
enzymes post exercise (i.e., LPL transcript) and exaggerated
IMCL accumulation in I-allele carriers after endurance training
(Vaughan et al., 2013). Interestingly, the higher post vs. pre-ratios
for lipid compounds (Figure 7B) in trained than untrained ACE-
DD carriers mirror the changes in RERpeak with training of this
genotype (Table S1), which is indicative of a reduced glucose
utilization in the trained subjects. While the extent to which
the metabolic alterations represents aerobic metabolism of lipids
awaits identification through the identification of affected non-
polar species, our results emphasize that the ACE I-allele confers
a metabolic advantage (i.e., substrate utilization) for endurance
performance by affecting muscle metabolism.
We observed a training-state-related inversion of the
ACE-I/D-dependent effects of exercise on muscle lipids and
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metabolites (Table S2). These training-related metabolic
differences between genotypes compare to larger differences
in capillary-to-fiber ratio between ACE I-allele carriers and
non-carriers in trained compared to untrained subjects
(Figures 3A,B). The findings indicate that the observed
genotype effect on muscle metabolites reflects an altered capacity
for capillary perfusion during exercise.
The notion of the influence of the ACE-I/D on the muscle
vasculature is supported by I-allele modulated level alterations
of the pro-angiogenic protein, VEGFA, 30-min post exercise,
irrespective of the training status (Figures 4C,D). VEGFA
expression is understood to be secreted from muscle fibers into
the interstitium with exercise and to bind and modify blood
vessels thereby enhancing their perfusion and proliferation (Mac
Gabhann et al., 2006; Hoier et al., 2013).
Respective to angiogenesis, we find that the exercise response
of tenascin-C protein levels demonstrates an interaction effect
between ACE-I/D genotype and training status (Figures 4E,F).
Similar to VEGFA, tenascin-C protein expression in human
skeletal muscle is associated mostly with capillary structures
and blood vessels in the interstitium, especially endothelial and
smooth muscle cells (reviewed by Valdivieso et al., 2017) and
is associated with exercise-induced angiogenesis through effects
on morphogenesis of blood vessel-associated cells (Valdivieso
et al., 2017). Both, VEGFA and tenascin-C expression and/or
secretion are affected by angiotensin 2 in different cell types
(Hahn et al., 1993; Gruden et al., 1999; Pupilli et al., 1999;
Alagappan et al., 2007; Ptasinska-Wnuk et al., 2007) and mediate
angiotensin 2-induced vascular reactions (Mackie et al., 1992;
Pupilli et al., 1999; Amaral et al., 2001; Ballard et al., 2006).
We identified negative correlations between serum angiotensin 2
concentrations and levels of VEGFA and tenascin-C proteins pre-
and post-exercise (Table S6). Possibly the observed interaction
between ACE-I/D genotype and training status for the exercise
response of tenascin-C, especially the 23% reduced levels in
untrained ACE-DD genotypes, reflects an angiotensin related
vaso-reactive response. In this regard, the interaction effect
of the ACE-I/D genotype and training status on capillary-to-
fiber ratio in m. vastus lateralis, and the correlations between
capillary-to-fiber ratio and serum angiotensin 2 concentrations
are of interest (Table S6). Collectively, these observations are
in line with the suggested role of angiotensin modulated
tenascin-C expression, and VEGFA expression, in exercise-
induced structural remodeling of capillaries (Mathes et al.,
2015; Vaughan et al., 2016). Tenascin-C and VEGFA are to a
different extent implied in the regulation of morphogenesis and
proliferation which control capillary growth by splitting and
sprouting angiogenesis, both of which are induced by exercise
(Williams et al., 2006; Valdivieso et al., 2017). The separable
effects of the ACE-I/D genotype and training status on post
exercise alterations of tenascin-C andVEGFA inmuscle therefore
suggest that the ACE-I/D genotype and training status may
differently modify the splitting and sprouting angiogenesis in
exercised muscle.
A role of the local ACE system for capillary reactions to
the studied one-legged stimulus is supported by the correlation
between capillary density and serum angiotensin 2 concentration
post exercise (r = 0.91). This emphasizes that the rise in serum
angiotensin 2 with exercise (Staessen et al., 1987) is related to
the surface area of capillary lumen in muscle where ACE situates
and is acutely activated by shear stress (Barauna et al., 2011).
In turn, this may lead to release of angiogenic proteins from
endothelial cells that lie down-stream, and/or vasoconstriction
of downstream vessels through the produced angiotensin 2.
The latter contention for a negative feedback mechanism of
ACE/angiotensin 2 regulation (Barauna et al., 2011) is supported
by the negative correlation between ACE transcript expression
and angiotensin 2 levels (r = −0.92) before exercise (Table S6);
possibly reflecting a negative relationship between the local
and systemic regulation of angiotensin 2 production at rest.
Intriguingly, ACE activity at rest was not dependent on ACE-I/D
genotype (p= 0.569) or training (p= 0.286), possibly suggesting
subtle effects and interferences (Kosunen et al., 1976) which were
not controlled in our investigation.
The suggestion of an exercise modulated local ACE system
is supported by the interaction effect of ACE-I/D genotype and
training status on ACE transcript levels in the studied knee
extensor muscle (Table S2, Figure 5). Thereby ACE transcript
levels were 28% lower in the untrained ACE I-allele carriers
than non-carriers whereas they were 237% higher in the trained
ACE I-allele carriers than non-carriers. The observed ACE I-
allele dependent up-regulation of the ACE transcripts in trained
subjects post exercise (Figure 5, Table S2) suggests that the
genetic mechanism, which silences ACE transcript expression, is
in part overridden by repeated exercise.
LIMITATION
This investigation was performed under several constraints.
First, this is a cross-sectional study. Thus, except for the period
between the recruitment and the tests, and measures of aerobic
capacity we did not control for the lifestyle and training. As
well, we identified post-hoc that age differed in association with
the ACE-I/D genotype (Table S1). This effect was explained
by an average of 8.2 and 8.7 years, respectively, higher age of
trained ACE-ID genotypes than ACE-DD (p = 0.001) and ACE-
II genotypes (p= 0.003). Despite the fact, that we did not identify
an association between age and training status, performance
measure or muscle parameter (Table S7), we cannot exclude the
possible role of age as a confounder in our investigation. In
line with previous observations, however, we identified effects
of the ACE-I/D genotype on muscle composition and found
sizable differences in the metabolic and angiogenic response
of muscle to the stimulus of exhaustive one-legged exercise.
Due to the invasive nature of the biopsy collection, we were
ethically bound to use as few subjects as possible. Thus, despite
the characterization of the metabolic response in a number of
subjects with our invasive approach, we found that the number
of homozygous ACE I-allele carriers remained small when
considering interactions of the ACE-I/D genotype with training.
We therefore primarily addressed the influence of the ACE I-
allele on metabolic variables as we previously identified that
this allele did produce a dominant effect on muscle parameters
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(Vaughan et al., 2013, 2016). Regarding the overall concern of
the assessed number of subjects we identify (based on effect sizes,
data not shown) that observed differences for muscle parameters
were considerably larger than what is commonly observed
for whole body parameters, thus allowing to expose gene ×
phenotypic associations with a rather high resolution. Functional
relevance of ACE-I allele related differences in muscle structure
is pointed out by the observation that peak aerobic power output
during one-legged and two-legged exercise was 19% higher
in ACE-II than ACE-DD genotypes and peak power output
during two-legged exercise remained 14% higher in trained
ACE-II than ACE-DD genotypes. Interestingly, interactions
between endurance training status and ACE-I/D genotype were
identified for muscle-based parameters of muscle performance,
such as CSA of m. vastus lateralis, MCSA and percentage of
the embedded type I muscle fibers, glycogen concentration, and
exercise-induced alterations in lipid species and peak respiration
exchange ratio (Figure 1). Muscle CSA, muscle fiber MCSA,
glycogen content and aerobic combustion of lipids in muscle
fibers set the capacity for continued force production (Jones
et al., 2004). Our present novel observations therefore indicate
that local metabolic effects of regular intense physical activity
may override in part the influence of the ACE-I/D genotype on
aerobic muscle performance. In this respect the lack of pre- and
post- exercise measures on blood flow is a considerable limitation
regarding mechanistic conclusions on the contribution of ACE-
I/D genotype and training modulated vasodilatation in exercised
muscle and warrants further exploration.
CONCLUSION
Our investigation documents a higher aerobic performance of
untrained ACE I-allele carriers of white British descent, which is
related to muscle and muscle fiber CSA, and capillarisation. The
observations further emphasize that repeated, intense exercise
(training) in part overrides ACE-I/D polymorphism mediated
genetic influences at the local muscle level on ACE expression
and the downstream angiogenic and metabolic response to
endurance exercise; and this is related to the increased muscle
capillarisation. The findings motivate further investigations
to address the mechanistic contribution of training-induced
modifications in angiotensin-controlled capillary perfusion and
angiogenic protein secretion in working muscle.
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Figure S1 | Correlation matrix of for muscle composition and endurance
performance. (A) P-value weighed correlations, i.e., only those relationships with a
p < 0.02 are shown, are shown in color coding. (B) Scatter plots of selected linear
relationships demonstrating significant correlations. The line of regression and the
95% confidence interval is shown along with the identified values for r2.
Table S1 | Interaction effects of training status and ACE-I/D genotype on
physiological characteristics. Values represent mean ± SD of baseline (i.e., pre)
values in function of training status and ACE-I/D genotype and the corresponding
p-values of the (interaction) effects over the 28 endurance-trained and 24
untrained subjects (untrained: 11xACE-DD, 10xACE-ID, 3xACE-II; trained:
15xACE-DD, 10xACE-ID, 3xACE-II) as assessed with univariate ANOVAs. BMI,
body mass index; BP, heart pressure; FFM, fat-free mass; PPO1, peak power
output during one-legged exercise; PPO, peak power output (during two-legged
exercise); FPPO, fraction of PPO at which the one-legged exercise was
performed; RERdelta1, difference between peak respiration exchange ratio during
one-legged exercise and rest; RERpeak1, peak respiration exchange ratio during
one-legged exercise; RERpeak, peak respiration exchange ratio during
two-legged exercise; RERrest1, respiration exchange ratio before the one-legged
exercise; RERpeak, respiration exchange ratio before two-legged exercise;
V˙O2peak1, peak oxygen uptake during one-legged exercise; V˙O2peak, peak
oxygen uptake (during two-legged exercise); V˙O2peakr1, body mass-related peak
oxygen uptake during one-legged exercise; V˙O2peakr, body mass-related peak
oxygen uptake during two-legged exercise; FV˙O2peak, fraction of V˙O2peak at
which the one-legged exercise was performed.
Table S2 | Interaction effects of training status and ACE-I/D genotype on
composition and angiogenic factor expression of skeletal muscle. Values
represent mean ± SD of baseline (i.e., pre) values in function of training status and
ACE-I/D genotype and the corresponding p-values of the (interaction) effects over
the 28 endurance-trained and 24 untrained subjects (Univariate ANOVA).
∗p < 0.05 vs. ACE-DD of same training status. $p < 0.05 vs. untrained of same
genotype. CD, capillary density; C:F, capillary-to-fiber ratio; PArea TypeI,
percentage of the muscle biopsy CSA being composed of being covered by type I
muscle fibers; PTypeI, percentage of type I muscle fibers.
Table S3 | Metabolites and lipids, which abundance differed between trained and
untrained subjects before exercise.
Table S4 | Metabolites (HMDB match) which abundance was affected with
exercise.
Table S5 | Lipids (LipidMaps match) which abundance was affected with exercise.
Table S6 | Correlations to elements of the ACE system in skeletal muscle. Pre and
post refer to the time point respective to one-legged exercise.
Table S7 | Associations between age and parameters of performance. P-values
of Chi-2 based tests between age and the indicated parameter.
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